Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cube Psytech Holdings Inc. T.P


Primary Symbol: P.CUUB

Healthcare Biotechnology
Cube Psytech intends to trade on the Canadian Security Exchange. There is no date set for the closing of their Initial Public Offering at this time.


P.CUUB - Post by User

Cube Psytech Holdings Inc. > Even with gold up
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by mary-ally-smithon Oct 29, 2016 8:40am
254 Views
Post# 25401475

RE:RE:RE:Even with gold up

RE:RE:RE:Even with gold up
Goldhound3 wrote: I hope you did'nt buy this stock at 2.25 the shorts are in control now as the stock has made a new 52 week low and if gold takes a dive when they raise rates in Dec we could see the stock hit a 1.50 or lower..


But POG could go also up and P may get back to 52 week high.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities